Published in Emerg Infect Dis on September 01, 2006
Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis (2010) 2.98
First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis (2008) 1.93
Risk factors for buruli ulcer: a case control study in Cameroon. PLoS Negl Trop Dis (2007) 1.90
Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis (2007) 1.53
Aquatic invertebrates as unlikely vectors of Buruli ulcer disease. Emerg Infect Dis (2008) 1.52
Whole genome comparisons suggest random distribution of Mycobacterium ulcerans genotypes in a Buruli ulcer endemic region of Ghana. PLoS Negl Trop Dis (2015) 1.51
Buruli ulcer disease prevalence in Benin, West Africa: associations with land use/cover and the identification of disease clusters. Int J Health Geogr (2008) 1.33
Detection of Mycobacterium ulcerans in the environment predicts prevalence of Buruli ulcer in Benin. PLoS Negl Trop Dis (2012) 1.27
A Landscape-based model for predicting Mycobacterium ulcerans infection (Buruli Ulcer disease) presence in Benin, West Africa. Ecohealth (2008) 1.26
Health services for Buruli ulcer control: lessons from a field study in Ghana. PLoS Negl Trop Dis (2011) 1.25
Buruli ulcer surveillance, Benin, 2003-2005. Emerg Infect Dis (2007) 1.20
Landscape diversity related to Buruli ulcer disease in Côte d'Ivoire. PLoS Negl Trop Dis (2008) 1.18
Family relationship, water contact and occurrence of Buruli ulcer in Benin. PLoS Negl Trop Dis (2010) 1.16
New foci of Buruli ulcer, Angola and Democratic Republic of Congo. Emerg Infect Dis (2008) 1.06
Buruli ulcer disease: prospects for a vaccine. Med Microbiol Immunol (2009) 1.05
Adequate wound care and use of bed nets as protective factors against Buruli Ulcer: results from a case control study in Cameroon. PLoS Negl Trop Dis (2011) 1.04
Buruli-ulcer induced disability in ghana: a study at apromase in the ashanti region. Plast Surg Int (2012) 0.96
Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and Benin. PLoS One (2015) 0.95
Risk factors for buruli ulcer in Ghana-a case control study in the Suhum-Kraboa-Coaltar and Akuapem South Districts of the eastern region. PLoS Negl Trop Dis (2014) 0.90
Perceptions on the effectiveness of treatment and the timeline of Buruli ulcer influence pre-hospital delay reported by healthy individuals. PLoS Negl Trop Dis (2013) 0.88
Single nucleotide polymorphisms on the road to strain differentiation in Mycobacterium ulcerans. J Clin Microbiol (2009) 0.86
Buruli Ulcer Disease and Its Association with Land Cover in Southwestern Ghana. PLoS Negl Trop Dis (2015) 0.84
Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo. PLoS Negl Trop Dis (2015) 0.84
Illness meanings and experiences for pre-ulcer and ulcer conditions of Buruli ulcer in the Ga-West and Ga-South Municipalities of Ghana. BMC Public Health (2012) 0.83
Lack of insertional-deletional polymorphism in a collection of Mycobacterium ulcerans isolates from Ghanaian Buruli ulcer patients. J Clin Microbiol (2009) 0.83
Disease ecology, health and the environment: a framework to account for ecological and socio-economic drivers in the control of neglected tropical diseases. Philos Trans R Soc Lond B Biol Sci (2017) 0.83
Contours of risk: spatializing human behaviors to understand disease dynamics in changing landscapes. Ecohealth (2012) 0.80
Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer. PLoS Negl Trop Dis (2016) 0.80
Regulation of mycolactone, the Mycobacterium ulcerans toxin, depends on nutrient source. PLoS Negl Trop Dis (2013) 0.77
Genotyping Tools for Mycobacterium ulcerans-Drawbacks and Future Prospects. Mycobact Dis (2014) 0.77
Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection. Open Forum Infect Dis (2016) 0.76
Socio-Environmental Factors Associated with the Risk of Contracting Buruli Ulcer in Tiassalé, South Côte d'Ivoire: A Case-Control Study. PLoS Negl Trop Dis (2016) 0.76
Application of geographical information system (GIS) technology in the control of Buruli ulcer in Ghana. BMC Public Health (2014) 0.75
Mycobacterium ulcerans low infectious dose and mechanical transmission support insect bites and puncturing injuries in the spread of Buruli ulcer. PLoS Negl Trop Dis (2017) 0.75
On the transmission dynamics of Buruli ulcer in Ghana: Insights through a mathematical model. BMC Res Notes (2015) 0.75
Evidences of the Low Implication of Mosquitoes in the Transmission of Mycobacterium ulcerans, the Causative Agent of Buruli Ulcer. Can J Infect Dis Med Microbiol (2017) 0.75
Insects in the transmission of Mycobacterium ulcerans infection. Lancet (1999) 4.46
Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire. Am J Trop Med Hyg (1995) 4.32
Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis (2002) 3.41
Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001. Emerg Infect Dis (2004) 3.08
Mycobacterium ulcerans in wild animals. Rev Sci Tech (2001) 2.84
Epidemiology of Mycobacterium ulcerans infection (Buruli ulcer) at Kinyara, Uganda. Trans R Soc Trop Med Hyg (1971) 2.16
Epidemiology of Buruli ulcer in Amansie West district, Ghana. Trans R Soc Trop Med Hyg (1994) 1.92
Aquatic snails, passive hosts of Mycobacterium ulcerans. Appl Environ Microbiol (2004) 1.91
Human Mycobacterium ulcerans infections developing at sites of trauma to skin. Am J Trop Med Hyg (1974) 1.89
Assessing water-related risk factors for Buruli ulcer: a case-control study in Ghana. Am J Trop Med Hyg (2004) 1.76
BCG: the challenge continues. Scand J Infect Dis (2001) 1.71
Potential role for fish in transmission of Mycobacterium ulcerans disease (Buruli ulcer): an environmental study. Appl Environ Microbiol (2004) 1.57
BCG vaccination against mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda. Lancet (1969) 1.55
Buruli ulcer distribution in Benin. Emerg Infect Dis (2005) 1.52
Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health (2004) 1.48
Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun (2004) 1.48
[Mycobacterium ulcerans cutaneous infections: Buruli ulcers]. Med Trop (Mars) (1995) 1.44
The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda. Trans R Soc Trop Med Hyg (1976) 1.42
Homologous and heterologous immunity in infections of mice with Mycobacterium ulcerans and Mycobacterium balnei. Am Rev Tuberc (1957) 1.37
A new Mycobacterium which caused skin infection. Microbiol Immunol (1982) 1.33
BURULI (MYCOBACTERIAL) ULCERATION IN UGANDA. (A NEW FOCUS OF BURULI ULCER IN MADI DISTRICT, UGANDA): REPORT OF A FIELD STUDY. East Afr Med J (1965) 1.33
The distribution and implications of BCG scars in northern Malawi. Bull World Health Organ (1989) 1.29
BCG scars in northern Malawi: sensitivity and repeatability of scar reading, and factors affecting scar size. Int J Tuberc Lung Dis (2000) 1.26
First reported case of Mycobacterium ulcerans infection in a patient from China. Trans R Soc Trop Med Hyg (2000) 1.19
Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer). Clin Diagn Lab Immunol (2002) 1.08
BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin. Am J Trop Med Hyg (2006) 1.06
First case of Mycobacterium ulcerans disease (Buruli ulcer) following a human bite. Clin Infect Dis (2003) 1.01
Epidemiologic observations on cases of Buruli ulcer seen in a hospital in the Lower Congo. Am J Trop Med Hyg (1970) 0.98
Methodological considerations in case-control studies to evaluate BCG vaccine effectiveness. Int J Epidemiol (1993) 0.80
Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001. Emerg Infect Dis (2004) 3.08
Psychosocial aspects of health seeking behaviours of patients with Buruli ulcer in southern Benin. Trop Med Int Health (2003) 2.07
Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium. J Clin Microbiol (2007) 1.79
Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg (2004) 1.69
Buruli ulcer recurrence, Benin. Emerg Infect Dis (2005) 1.69
Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo. Cell Microbiol (2005) 1.61
Analysis of cost outliers within APR-DRGs in a Belgian general hospital: two complementary approaches. Health Policy (2006) 1.37
Fine-needle aspiration, an efficient sampling technique for bacteriological diagnosis of nonulcerative Buruli ulcer. J Clin Microbiol (2009) 1.34
Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members. Trans R Soc Trop Med Hyg (2008) 1.32
Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients. Trop Med Int Health (2005) 1.29
Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis (2008) 1.26
Stroke presentation and outcome in developing countries: a prospective study in the Gambia. Stroke (2005) 1.24
Buruli ulcer surveillance, Benin, 2003-2005. Emerg Infect Dis (2007) 1.20
Association of HIV infection and Mycobacterium ulcerans disease in Benin. AIDS (2008) 1.08
Environmental and health-related risk factors for Mycobacterium ulcerans disease (Buruli ulcer) in Benin. Am J Trop Med Hyg (2007) 1.07
BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin. Am J Trop Med Hyg (2006) 1.06
Prospective casemix-based funding, analysis and financial impact of cost outliers in all-patient refined diagnosis related groups in three Belgian general hospitals. Eur J Health Econ (2006) 1.04
First case of Mycobacterium ulcerans disease (Buruli ulcer) following a human bite. Clin Infect Dis (2003) 1.01
Insertion sequence element single nucleotide polymorphism typing provides insights into the population structure and evolution of Mycobacterium ulcerans across Africa. Appl Environ Microbiol (2013) 0.98
The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS. Vaccine (2009) 0.96
[Simplified prognostic model of overall intrahospital mortality of children in central Africa]. Trop Med Int Health (2006) 0.96
Randomized controlled trial of the effectiveness of a soybean-maize-sorghum-based ready-to-use complementary food paste on infant growth in South Kivu, Democratic Republic of Congo. Am J Clin Nutr (2012) 0.95
High perinatal mortality rate among immigrants in Brussels. Eur J Public Health (2010) 0.93
Bacterial contamination of indoor air, surfaces, and settled dust, and related dust endotoxin concentrations in healthy office buildings. Ann Agric Environ Med (2005) 0.91
Reliability and validity of the Buruli ulcer functional limitation score questionnaire. Am J Trop Med Hyg (2005) 0.91
[Profile of members and non members of mutual health insurance system in Rwanda: the case of the health district of Kabutare]. Trop Med Int Health (2004) 0.91
Fluid intake survey among schoolchildren in Belgium. BMC Public Health (2014) 0.89
Nutritional monitoring of preschool-age children by community volunteers during armed conflict in the Democratic Republic of the Congo. Food Nutr Bull (2009) 0.89
Effects of grinding surgical tissue specimens and smear staining methods on Buruli ulcer microscopic diagnosis. Trop Med Int Health (2008) 0.88
Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study. Curr Med Res Opin (2005) 0.87
Population-based study on occupational risk factors for preeclampsia and gestational hypertension. Scand J Work Environ Health (2007) 0.86
Mycobacterium ulcerans disease (Buruli ulcer) following human bite. Lancet (2002) 0.83
Cord C-peptide and insulin-like growth factor-I, birth weight, and placenta weight among North African and Belgian neonates. Am J Obstet Gynecol (2003) 0.80
[Factors associated with malnutrition in children aged under five years in Lubumbashi (DRC)]. Sante Publique (2011) 0.79
Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study. Curr Med Res Opin (2009) 0.79
Association between haemoglobin variants S and C and Mycobacterium ulcerans disease (Buruli ulcer): a case-control study in Benin. Trop Med Int Health (2007) 0.78
Does a small difference in iodine status among children in two regions of Belgium translate into a different prevalence of thyroid nodular diseases in adults? Eur J Nutr (2011) 0.78
Effect of adopting host-country nationality on perinatal mortality rates and causes among immigrants in Brussels. Eur J Obstet Gynecol Reprod Biol (2013) 0.78
Costs of treatment of children affected by severe malaria in reference hospitals of Kinshasa, Democratic Republic of Congo. J Infect Dev Ctries (2014) 0.77
Schistosoma haematobium infection and Buruli ulcer. Emerg Infect Dis (2004) 0.75
[Postpartum women with unknown HIV status in Lubumbashi, DR Congo: proportion and determinants]. Pan Afr Med J (2012) 0.75
Belgian global implementation of cardiovascular and stroke risk assessment study: methods and baseline data of the BELGICA-STROKE STUDY. Eur J Cardiovasc Prev Rehabil (2011) 0.75
[Quality of care given to seriously ill children in a provincial hospital in central Africa]. Sante Publique (2007) 0.75
[Intra-hospital mortality of children in central Africa: looking at the impact of a training programme and increased supervision]. Sante Publique (2010) 0.75
[In Process Citation]. Sante Publique (2016) 0.75